Idea Acquisition Corp. 8-K

What Happened

• Idea Acquisition Corp. announced it completed its IPO on February 12, 2026, selling 35,000,000 units at $10.00 each for gross proceeds of $350,000,000. Each unit contains one Class A ordinary share and one‑third of a warrant (each full warrant exercisable at $11.50, subject to adjustment).
• Simultaneously, the company completed a private placement of 6,000,000 warrants at $1.50 each (gross proceeds $9,000,000). Purchasers: Sponsor (3,666,667 warrants), Cantor Fitzgerald & Co. as representative (1,633,333), and Odeon Capital Group (700,000).
• The $350M of IPO proceeds (which may include up to $14M of underwriters’ deferred commission) plus the private placement proceeds were placed in a U.S.-based trust account held by Continental; funds will generally remain in trust until the SPAC completes an initial business combination or is liquidated under the timelines in the governing documents.

Key Details

• IPO: 35,000,000 units at $10.00 = $350,000,000 gross proceeds (Feb 12, 2026 closing).
• Private placement: 6,000,000 warrants at $1.50 each = $9,000,000; warrants are similar to IPO warrants but have transfer restrictions, cashless exercise rights, registration rights, and (for underwriter-held warrants) a 5‑year expiry for exercise.
• Governance: On Feb 10, 2026 the board added Eugene “Rod” Roddenberry Jr., Jules Urbach and Vinny Lingham (all independent); committee assignments and a three-class director structure were established.
• Corporate: The company adopted amended and restated governing documents effective Feb 10, 2026; press releases announcing pricing and closing were issued Feb 10 and Feb 12.

Why It Matters

• The company now has substantial cash in trust ($350M), which is the pool of capital intended to fund a future merger or acquisition (the “initial business combination”). These funds are largely restricted and generally cannot be used until a business combination is completed or the SPAC liquidates per the announced timeline (typically 24 months).
• Warrants create potential future dilution if exercised; the private placement warrants have different transfer and exercise features than the public warrants, which can affect liquidity and timing for those holders.
• New independent directors and the updated governance documents are important for oversight of the SPAC’s search for a target and for shareholder protections during the pre‑combination period.